Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

XCUR – Exicure Inc.

XCUR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

14.15

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.27

Target Price

10.33

Analyst Recom

1

Performance Q

-60.9

Upside

-1,628.2%

Beta

3.62

Ticker: XCUR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13XCUR1.63N/AN/A0
2026-07-14XCUR1.705N/AN/A0
2026-07-15XCUR1.63N/AN/A0
2026-07-16XCUR1.6N/AN/A0
2026-07-17XCUR1.72N/AN/A0
2026-07-20XCUR1.89N/AN/A0
2026-07-21XCUR1.9N/AN/A0
2026-07-22XCUR1.71N/AN/A0
2026-07-23XCUR1.71N/AN/A0
2026-07-24XCUR1.73N/AN/A0
2026-07-27XCUR1.74N/AN/A0
2026-07-28XCUR1.71N/AN/A0
2026-07-29XCUR1.73N/AN/A0
2026-07-30XCUR1.61N/AN/A0
2026-07-31XCUR1.63N/AN/A0
2026-08-03XCUR1.51N/AN/A0
2026-08-04XCUR1.55N/AN/A0
2026-08-05XCUR1.57N/AN/A0
2026-08-06XCUR1.33N/AN/A0
2026-08-07XCUR1.305N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13XCUR1.65- - -
2026-07-14XCUR1.66- - -
2026-07-15XCUR1.62- - -
2026-07-16XCUR1.59- - -
2026-07-17XCUR1.65- - -
2026-07-20XCUR1.89- - -
2026-07-21XCUR1.90- - -
2026-07-22XCUR1.71- - -
2026-07-23XCUR1.71- - -
2026-07-24XCUR1.74- - -
2026-07-27XCUR1.73- - -
2026-07-28XCUR1.72- - -
2026-07-29XCUR1.74- - -
2026-07-30XCUR1.60- - -
2026-07-31XCUR1.64- - -
2026-08-03XCUR1.59- - -
2026-08-04XCUR1.59- - -
2026-08-05XCUR1.51- - -
2026-08-06XCUR1.31- - -
2026-08-07XCUR1.27- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13XCUR-31.43-0.010.16
2026-07-14XCUR-31.43-0.010.16
2026-07-15XCUR-31.41-0.010.16
2026-07-16XCUR-31.43-0.010.16
2026-07-17XCUR-31.41-0.010.16
2026-07-20XCUR-31.42-0.010.16
2026-07-21XCUR-10.65-0.010.16
2026-07-22XCUR0.00-0.010.16
2026-07-23XCUR0.00-0.010.16
2026-07-24XCUR0.00-0.010.16
2026-07-27XCUR0.00-0.0214.15
2026-07-28XCUR0.00-0.0214.15
2026-07-29XCUR0.00-0.0214.15
2026-07-30XCUR0.00-0.0214.15
2026-07-31XCUR0.00-0.0214.15
2026-08-03XCUR0.00-0.0214.15
2026-08-04XCUR0.00-0.0214.15
2026-08-05XCUR0.00-0.0214.15
2026-08-06XCUR0.00-0.0214.15
2026-08-07XCUR0.00-0.0214.15
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.02

Beta

3.62

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

Sentiment Score

1

Actual DrawDown %

99.4

Max Drawdown 5-Year %

-99.4

Target Price

10.33

P/E

Forward P/E

PEG

P/S

P/B

3.98

P/Free Cash Flow

EPS

-1.54

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.1

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

XCUR Healthcare
$1.31
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
11/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
27.9
Range 1M
4.4%
Sup Dist
2.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
11 /100
WEAK
Momentum
7/25
Growth
4/30
Estimates
0/20
Inst/Vol
0/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
0.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +688.5% upside
Quality
2/30
Valuation
16/30
Growth
0/25
Stability
4/10
LT Trend
4/5
Upside
+688.5%
Quality
4
XCUR — P/E HistoricalBiotechnology
Exicure, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 2
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR

Latest News

Caricamento notizie per XCUR
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading